<SEC-DOCUMENT>0001564590-20-036208-index.html : 20200818 <SEC-HEADER>0001564590-20-036208.hdr.sgml : 20200818 <ACCEPTANCE-DATETIME>20200804180433 ACCESSION NUMBER: 0001564590-20-036208 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20200803 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-80623 FILM NUMBER: 201074611 BUSINESS ADDRESS: STREET 1: 520 PIKE STREET STREET 2: SUITE 2250 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 520 PIKE STREET STREET 2: SUITE 2250 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>achv-8k_20200803.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: achv-8k_20200803.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>achv-ex11_10.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: achv-ex11_10.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>3 <FILENAME>achv-ex41_11.htm <DESCRIPTION>EX-4.1 <TEXT> Document 3 - file: achv-ex41_11.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>4 <FILENAME>achv-ex51_6.htm <DESCRIPTION>EX-5.1 <TEXT> Document 4 - file: achv-ex51_6.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>gdsgakqbhf23000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: gdsgakqbhf23000001.jpg
</DOCUMENT> </SEC-DOCUMENT>